Featured
Advertisement
-
-
CRISPR screens identify STUB1 as an inhibitor of cytokine signaling in CD8+ T cells
Using in vivo CRISPR–Cas9 screens of CD8+ T cells in a melanoma model, we identified STUB1 as an inhibitor of T cell-mediated antitumor immunity. STUB1 forms a complex with CHIC2, and together, they negatively regulate the expression of cytokine receptors, thereby limiting intratumoral CD8+ T cell numbers and function.
-
-
Trending - Altmetric
-
CGRP-related neuropeptide adrenomedullin 2 promotes tissue-protective ILC2 responses and limits intestinal inflammation
-
CD1a on Langerhans cells controls inflammatory skin disease
-
A STUB1–CHIC2 complex inhibits CD8+ T cells to restrain tumor immunity
-
SATB1 is a key regulator of quiescence in stem-like CD8+ T cells